HEARING HEALTHCARE CENTRE LIMITEDActive

Company number 04679641Private limited companyIncorporated 2003
⚠ Confirmation statement overdue. It was due on 25 Oct 2026.

Key figures

£313,305-2.1%
Net assets 2024/25
+12.8%
Average annual growth 2019/20–2024/25
0100 k200 k300 k400 k2019/202020/212021/222023/242024/25

Like most small UK companies, HEARING HEALTHCARE CENTRE LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
0200 k400 k600 k2019/202020/212021/222023/242024/25
Filed accounts2019/20–2024/25
2019/202020/212021/222023/242024/25
Cash at bank and in hand189,052324,666345,598376,763—
Total assets300,052391,814415,560412,582374,183
Total liabilities————61,629
Net assets / total equity193,744274,964299,479320,099313,305
Average number of employees95645

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Summary: HEARING HEALTHCARE CENTRE LIMITED

Company

HEARING HEALTHCARE CENTRE LIMITED is a private limited company registered with Companies House under company number 04679641. It was incorporated on 26 Feb 2003. Its status is active. The registered office is in Cambridge (CB4). Its nature of business (SIC 2007) is other human health activities (86900).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files micro-entity accounts. Net assets were £313,305, down 2.1% on the previous year. Total assets were £374,183 and total liabilities £61,629. The company had an average of 5 employees. Figures are available for 5 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 25 Oct 2026.